Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.23.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 6,532 $ 4,181
Accounts receivable, less allowance of $2,124 and $2,164 as of March 31, 2023 and December 31, 2022, respectively 5,158 5,841
Inventory 17,775 15,884
Prepaid expenses and other current assets 2,499 3,053
Total current assets 31,964 28,959
Property, plant, and equipment, net 4,719 4,278
Goodwill 2,926 2,926
Right of use asset 2,078 1,768
Other assets 257 255
Total assets 41,944 38,186
Current liabilities:    
Accounts payable 7,540 5,786
Accrued liabilities 7,977 9,210
Deferred revenue, current portion 2,082 2,111
Current portion of term loans, net of discount 1,400 700
Total current liabilities 18,999 17,807
Deferred revenue 355 418
Warranty accrual 426 360
Non current term loans, net of discount 12,496 13,091
Non current operating lease liability 1,432 1,259
Other liabilities 78 362
Total liabilities 33,786 33,297
Stockholders' equity:    
Common stock, par value $0.001 per share; 180,000 shares authorized, 26,329 and 7,723 shares issued and 26,327 and 7,721 shares outstanding as of March 31, 2023 and December 31, 2022, respectively 26 8
Additional paid-in-capital 310,802 301,782
Accumulated other comprehensive loss (653) (733)
Accumulated deficit (302,017) (296,168)
Total stockholders' equity 8,158 4,889
Total liabilities, redeemable preferred stock and stockholders' equity $ 41,944 $ 38,186